Sign in

CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
383982704
Phone
6096193990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
  1. 3 Insider Initial Statement of Ownership
  2. 4 Insider Changes in Ownership
  3. SC 13D/A Stake Beneficial Ownership Report
  4. 8-K Event Executive or director change · Shareholder vote results · Other events
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 8-K Event Delisting notice
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. DEFA14A Proxy Proxy Materials
  12. DEF 14A Proxy Proxy Statement
  13. UPLOAD Other SEC-generated Letter
  14. PRER14A Other PRER14A
  15. UPLOAD Other SEC-generated Letter
  16. D Other Notice of Sales of Unregistered Securities
  17. 3/A Insider 3/A
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 35 of 42 · 833 filings